Dasatinib Accord ইউরোপীয় ইউনিয়ন - লাত্‌ভীয় - EMA (European Medicines Agency)

dasatinib accord

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiski līdzekļi - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.

Dasatinib Accordpharma ইউরোপীয় ইউনিয়ন - লাত্‌ভীয় - EMA (European Medicines Agency)

dasatinib accordpharma

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiski līdzekļi - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Doxorubicin-Teva 10 mg pulveris injekciju šķīduma pagatavošanai লাত্ভিয়া - লাত্‌ভীয় - Zāļu valsts aģentūra

doxorubicin-teva 10 mg pulveris injekciju šķīduma pagatavošanai

teva pharma b.v., netherlands - doksorubicīna hidrohlorīds - pulveris injekciju šķīduma pagatavošanai - 10 mg

Doxorubicin-Teva 50 mg pulveris injekciju šķīduma pagatavošanai লাত্ভিয়া - লাত্‌ভীয় - Zāļu valsts aģentūra

doxorubicin-teva 50 mg pulveris injekciju šķīduma pagatavošanai

teva pharma b.v., netherlands - doksorubicīna hidrohlorīds - pulveris injekciju šķīduma pagatavošanai - 50 mg

Quinapril/HCT Teva 20 mg/12,5 mg apvalkotās tabletes লাত্ভিয়া - লাত্‌ভীয় - Zāļu valsts aģentūra

quinapril/hct teva 20 mg/12,5 mg apvalkotās tabletes

teva pharma b.v., netherlands - quinaprilum, hydrochlorothiazidum - apvalkotā tablete - 20 mg/12,5 mg